These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19570081)

  • 21. Acute fulminant visceral leishmaniasis in children--a report of two cases.
    Pahwa R; Gupta SK; Singh T; Nigam S
    Indian J Pathol Microbiol; 2004 Jul; 47(3):428-30. PubMed ID: 16295448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant kala-azar, malaria, and progressive unstable indeterminate leprosy in an 8-year-old child.
    Saha K; Chattopadhya D; Kulpati DD
    J Trop Pediatr; 1998 Aug; 44(4):247-8. PubMed ID: 9718914
    [No Abstract]   [Full Text] [Related]  

  • 23. [Visceral leishmaniasis (kala-azar) as an opportunistic infection in immunosuppressed patients].
    Lüthy RM; Kistler HJ
    Schweiz Med Wochenschr; 1989 Sep; 119(38):1309-13. PubMed ID: 2587969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Post-kala-azar dermal leishmaniasis or diffuse cutaneous leishmaniasis].
    Cavelier B; Bertail MA; Chemaly P; Bonvalet D; Civatte J
    Ann Dermatol Venereol; 1984; 111(6-7):579-86. PubMed ID: 6497254
    [No Abstract]   [Full Text] [Related]  

  • 26. Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal.
    Chappuis F; Rijal S; Jha UK; Desjeux P; Karki BM; Koirala S; Loutan L; Boelaert M
    Trop Med Int Health; 2006 Jan; 11(1):31-40. PubMed ID: 16398753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphadenopathy in a child with Indian kala-azar in Dharan, Nepal.
    Singh K; Singh R; Parija SC
    Indian Pediatr; 1998 Nov; 35(11):1125-6. PubMed ID: 10216552
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypopigmented post-kala-azar dermal leishmaniasis.
    Ramesh V; Ramam M; Singh R; Salotra P
    Int J Dermatol; 2008 Apr; 47(4):414-6. PubMed ID: 18377613
    [No Abstract]   [Full Text] [Related]  

  • 29. Photo quiz. Visceral leishmaniasis with hemophagocytic syndrome.
    Bessis D; Sotto A; Taib J; Ciurana AJ
    Clin Infect Dis; 1993 Oct; 17(4):611, 829. PubMed ID: 8268339
    [No Abstract]   [Full Text] [Related]  

  • 30. Comment: distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan.
    Babu VV
    Lepr Rev; 1994 Jun; 65(2):150. PubMed ID: 7968192
    [No Abstract]   [Full Text] [Related]  

  • 31. Bone marrow fibrosis (pseudo-myelofibrosis) in human kala-azar.
    Rocha Filho FD; Ferreira FV; Mendes Fde O; Ferreira FN; Karbage A; Alencar ML; Costa D
    Rev Soc Bras Med Trop; 2000; 33(4):363-6. PubMed ID: 10936949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 34. A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.
    Adhikari SR; Supakankunti S
    J Vector Borne Dis; 2010 Sep; 47(3):127-39. PubMed ID: 20834081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of molecular approaches to distinguish post kala-azar dermal leishmaniasis from leprosy: A case study.
    Roy S; Roy M; Nath S; Chaudhuri SJ; Ghosh MK; Mukherjee S; Chatterjee M
    Indian J Dermatol Venereol Leprol; 2023; 89(2):298-300. PubMed ID: 36461804
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case report of skin manifestations in infantile Mediterranean kala-azar].
    Ayadi A; Loukil M; Lakhoua R; Boubaker S; Debbabi A; Ben Rachid SB; Jedidi H
    Ann Pediatr (Paris); 1992 Apr; 39(4):265-7. PubMed ID: 1616241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post kala-azar dermal leishmaniasis.
    Munro DD; Du Vivier A; Jopling WH
    Br J Dermatol; 1972 Oct; 87(4):374-8. PubMed ID: 5077868
    [No Abstract]   [Full Text] [Related]  

  • 38. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
    Ramesh V; Singh R; Salotra P
    Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Visceral and cutaneous leishmaniasis].
    Mirejovský P; Bednár B; Kodetová D; Stejskal J
    Cesk Patol; 1996 May; 32(2):70-4. PubMed ID: 9560904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The nephropathy of kala-azar].
    Andrade ZA; Iabuki K
    Rev Inst Med Trop Sao Paulo; 1972; 14(1):51-4. PubMed ID: 4113239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.